J&J/Basilea’s Ceftobiprole Gets Another Setback
FDA stops the investigational antibiotic’s six-month review clock for additional clinical site audits, data integrity review.
FDA stops the investigational antibiotic’s six-month review clock for additional clinical site audits, data integrity review.